| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.2M | +4.1% | +3.3% |
| R&D Expense | $1.3M | +1.4% | -23.6% |
| SG&A Expense | $5.6M | -0.2% | +4.7% |
| Operating Income | -$11.8M | -3.3% | -0.6% |
| Interest Expense | $2K | -66.7% | +100.0% |
| Pre-tax Income | -$10.4M | -134.2% | +16.0% |
| Net Income | -$10.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $47.3M | +52.1% | +226.7% |
| Accounts Receivable | $550K | +47.5% | +1310.3% |
| Inventory | $486K | -3.8% | -25.3% |
| Current Assets | $49.8M | +47.3% | +196.3% |
| Total Assets | $53.2M | +37.6% | +135.4% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$33.9M | — | — |
| Investing Cash Flow | -$146K | — | — |
| Financing Cash Flow | $59.0M | — | — |
| -134.2% |
| +16.0% |
| EPS (Basic) | -$0.10 | -25.0% | +60.0% |
| EPS (Diluted) | -$0.10 | -25.0% | +60.0% |
| $26.2M |
| -10.9% |
| +83.9% |
| Total Liabilities | $27.4M | -11.2% | +68.3% |
| Stockholders' Equity | $25.8M | +228.6% | +307.6% |